Clinical Trial Update: Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of an antibody linked to chemotherapy for triple-negative metastatic breast cancer; trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Triple Negative Breast Cancer, Metastatic Breast Cancer | Phase 3 | Status: RECRUITING